QC Specialist
赛纽仕医药咨询（上海）有限公司
- 公司规模：500-1000人
- 公司性质：外资（欧美）
- 公司行业：制药/生物工程
职位信息
- 发布日期：2024-08-02
- 工作地点：大连
- 工作经验：3年及以上
- 学历要求：大专
- 职位月薪：7-9千
- 职位类别：QC Specialist
职位描述
JOB SUMMARY
根据SOP要求检查专员工作，整理保存项目资料，协助QC经理完成项目要求。
JOB RESPONSIBILITIES
1、检查专员每天的工作记录，对核查出的问题提出整改； 2、检查是否漏报AE，确保专员无漏报AE，及时上报AE，监督专员报告及处理流程符合公司相关要求; 3、检查ICF填写规范，负责对项目文档进行整理归档； 4、每月项目月度汇总报表 ; 5、参与更新公司的QC流程及规范，如标准操作规程（SOP）工作指南; 6、根据项目需要，给项目组成员提供相关表格填写以及AE培训 ; 7、参与监管部门的审查。
QUALIFICATION REQUIREMENTS (please indicate if ‘preferred’)
1、临床医学/药学专科以上学历；
2、患者管理项目及相关领域质控三年以上经验；
3、熟练的计算机操作技能
根据SOP要求检查专员工作，整理保存项目资料，协助QC经理完成项目要求。
JOB RESPONSIBILITIES
1、检查专员每天的工作记录，对核查出的问题提出整改； 2、检查是否漏报AE，确保专员无漏报AE，及时上报AE，监督专员报告及处理流程符合公司相关要求; 3、检查ICF填写规范，负责对项目文档进行整理归档； 4、每月项目月度汇总报表 ; 5、参与更新公司的QC流程及规范，如标准操作规程（SOP）工作指南; 6、根据项目需要，给项目组成员提供相关表格填写以及AE培训 ; 7、参与监管部门的审查。
QUALIFICATION REQUIREMENTS (please indicate if ‘preferred’)
1、临床医学/药学专科以上学历；
2、患者管理项目及相关领域质控三年以上经验；
3、熟练的计算机操作技能
公司介绍
About Syneos Health
Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit ****************.
* We expect Syneos Health common shares to trade on the Nasdaq Global Select Market under the new name and new ticker symbol “SYNH” by January 9, 2018. Until then, Syneos Health will continue to be listed under INC Research Holdings, Inc. and the symbol “INCR.”
FOR USE AFTER JANUARY 9
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit ****************.
Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit ****************.
* We expect Syneos Health common shares to trade on the Nasdaq Global Select Market under the new name and new ticker symbol “SYNH” by January 9, 2018. Until then, Syneos Health will continue to be listed under INC Research Holdings, Inc. and the symbol “INCR.”
FOR USE AFTER JANUARY 9
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit ****************.
联系方式
- 公司地址：上海市静安区南京西路688号506室 (邮编：200041)